STOCK TITAN

Director Paul Stuka adds 7,895 InspireMD (NSPR) shares in open‑market buys

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

InspireMD, Inc. director Paul Stuka increased his stake through open-market purchases of Common Stock. On May 7, 2026, he bought 6,378 shares at $1.15 per share, and on May 6, 2026 he bought 1,517 shares at $1.12 per share. After these transactions, he directly holds 531,599 shares of InspireMD common stock. A footnote explains that the May 7 price reflects a weighted average for multiple trades executed between $1.14 and $1.15 per share.

Positive

  • None.

Negative

  • None.
Insider Stuka Paul
Role null
Bought 7,895 shs ($9K)
Type Security Shares Price Value
Purchase Common Stock 6,378 $1.15 $7K
Purchase Common Stock 1,517 $1.12 $2K
Holdings After Transaction: Common Stock — 531,599 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Total shares purchased 7,895 shares Open-market purchases on May 6–7, 2026
May 6 purchase 1,517 shares at $1.12/share Open-market purchase of Common Stock
May 7 purchase 6,378 shares at $1.15/share Open-market purchase; price is weighted average
Post-transaction holdings 531,599 shares Direct ownership after May 7, 2026 transaction
Weighted price range $1.14–$1.15/share Price range for May 7, 2026 trades
open-market purchase financial
"transaction_action: "open-market purchase" for Common Stock transactions"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"security_title: "Common Stock" in each reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4): { "issuerName": "InspireMD, Inc.""
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stuka Paul

(Last)(First)(Middle)
C/O INSPIREMD, INC.
6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)
MIAMI FLORIDA 33126

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026P1,517A$1.12525,221D
Common Stock05/07/2026P6,378A$1.15(1)531,599D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.14 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did InspireMD (NSPR) report for Paul Stuka?

InspireMD reported that director Paul Stuka made two open-market purchases of Common Stock. He bought 1,517 shares on May 6, 2026 at $1.12 per share and 6,378 shares on May 7, 2026 at $1.15 per share.

How many InspireMD (NSPR) shares did Paul Stuka buy in total?

Across the two reported transactions, director Paul Stuka bought a total of 7,895 shares of InspireMD Common Stock. These were open-market purchases executed on May 6 and May 7, 2026 at prices of $1.12 and $1.15 per share, respectively.

What is Paul Stuka’s InspireMD (NSPR) shareholding after these Form 4 trades?

Following the reported purchases, director Paul Stuka directly owns 531,599 shares of InspireMD Common Stock. This post-transaction holding figure comes from the Form 4, which lists total shares following the May 7, 2026 open-market purchase transaction.

At what prices did Paul Stuka’s InspireMD (NSPR) transactions occur?

The Form 4 shows purchases at $1.12 per share on May 6, 2026 and $1.15 per share on May 7, 2026. A footnote notes that the May 7 price is a weighted average for trades between $1.14 and $1.15.

What does the weighted average price footnote mean in the InspireMD (NSPR) Form 4?

The footnote explains that the $1.15 price is a weighted average for multiple trades executed between $1.14 and $1.15 per share. The reporting person offers to provide full details on the number of shares traded at each individual price within that range.